Dentsply Sirona exec leaving as internal probe of financial irregularities expands


Dentsply Sirona says its internal investigation into financial-reporting irregularities has expanded. The company warns that preliminary quarterly results released in May will have to be corrected and that 2021 financials may have to be restated.

Previous Verona Pharma sees stock jump as COPD drug returns positive results
Next Immunology startup GentiBio signs $1.9B deal with Bristol Myers